Inhibition of sodium–glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of sodium–glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization
Authors
Keywords
-
Journal
BASIC RESEARCH IN CARDIOLOGY
Volume 114, Issue 3, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-04-19
DOI
10.1007/s00395-019-0733-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?
- (2019) Carlos G. Santos-Gallego et al. CARDIOVASCULAR DRUGS AND THERAPY
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects
- (2017) Ioanna Andreadou et al. Frontiers in Physiology
- Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes
- (2017) Shin Kawasoe et al. BMC Pharmacology & Toxicology
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
- (2017) Kenneth W. Mahaffey et al. CIRCULATION
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
- (2016) Hiddo J.L. Heerspink et al. CIRCULATION
- Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
- (2016) Sunder Mudaliar et al. DIABETES CARE
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery
- (2015) Ying Han et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Altered Myocardial Calcium Cycling and Energetics in Heart Failure—A Rational Approach for Disease Treatment
- (2015) Przemek A. Gorski et al. Cell Metabolism
- Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor
- (2015) Damayanthi Devineni et al. CLINICAL PHARMACOKINETICS
- Sodium–Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport
- (2015) Sunder Mudaliar et al. DIABETES CARE
- Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
- (2015) R. Chilton et al. DIABETES OBESITY & METABOLISM
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
- (2014) David ZI Cherney et al. Cardiovascular Diabetology
- Evaluating SGLT2 inhibitors for type 2 diabetes: pharmacokinetic and toxicological considerations
- (2014) André J Scheen Expert Opinion on Drug Metabolism & Toxicology
- Malonyl CoA: A promising target for the treatment of cardiac disease
- (2014) Natasha Fillmore et al. IUBMB LIFE
- The Na+/H+exchanger and pH regulation in the heart
- (2014) Ayodeji Odunewu-Aderibigbe et al. IUBMB LIFE
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
- (2014) Ele Ferrannini et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus
- (2013) Damayanthi Devineni et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Mitochondria as a Therapeutic Target in Heart Failure
- (2012) Marina Bayeva et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The in-situ pig heart with regional ischemia/reperfusion — Ready for translation
- (2011) Gerd Heusch et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The effect of insulin on the heart
- (2011) L. J. Klein et al. Netherlands Heart Journal
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
- (2010) Jian Chen et al. Diabetes Therapy
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started